97 related articles for article (PubMed ID: 26717877)
21. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
22. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
23. microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer.
Yang Q; Jiang W; Zhuang C; Geng Z; Hou C; Huang D; Hu L; Wang X
Oncol Rep; 2015 Oct; 34(4):1771-8. PubMed ID: 26239725
[TBL] [Abstract][Full Text] [Related]
24. Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells.
Tanaka M; Kitadai Y; Kodama M; Shinagawa K; Sumida T; Tanaka S; Oue N; Yasui W; Chayama K
Cancer Sci; 2010 Oct; 101(10):2121-7. PubMed ID: 20626397
[TBL] [Abstract][Full Text] [Related]
25. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
Habib R; Akhtar J; Taqi M; Yu C; Zhang C
Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
[TBL] [Abstract][Full Text] [Related]
27. Silencing insulin-like growth factor-1 receptor expression inhibits gastric cancer cell proliferation and invasion.
Ge J; Chen Z; Huang J; Yuan W; Den Z; Chen Z
Mol Med Rep; 2015 Jan; 11(1):633-8. PubMed ID: 25339573
[TBL] [Abstract][Full Text] [Related]
28. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of galectin-7 in epithelial ovarian cancer.
Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
[TBL] [Abstract][Full Text] [Related]
30. Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.
Delgado VM; Nugnes LG; Colombo LL; Troncoso MF; Fernández MM; Malchiodi EL; Frahm I; Croci DO; Compagno D; Rabinovich GA; Wolfenstein-Todel C; Elola MT
FASEB J; 2011 Jan; 25(1):242-54. PubMed ID: 20876211
[TBL] [Abstract][Full Text] [Related]
31. Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex.
Wu MH; Ying NW; Hong TM; Chiang WF; Lin YT; Chen YL
Angiogenesis; 2014 Oct; 17(4):839-49. PubMed ID: 24719187
[TBL] [Abstract][Full Text] [Related]
32. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells.
Jiao XL; Zhao C; Niu M; Chen D
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1709-15. PubMed ID: 23852892
[TBL] [Abstract][Full Text] [Related]
34. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H
Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887
[TBL] [Abstract][Full Text] [Related]
35. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
36. Zerumbone inhibits tumor angiogenesis via NF-κB in gastric cancer.
Tsuboi K; Matsuo Y; Shamoto T; Shibata T; Koide S; Morimoto M; Guha S; Sung B; Aggarwal BB; Takahashi H; Takeyama H
Oncol Rep; 2014 Jan; 31(1):57-64. PubMed ID: 24220661
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer.
Xu C; Li W; Qiu P; Xia Y; Du X; Wang F; Shen L; Chen Q; Zhao Y; Jin R; Wu J; Liang G; Li X
Anticancer Drugs; 2015 Apr; 26(4):379-87. PubMed ID: 25521558
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
[TBL] [Abstract][Full Text] [Related]
39. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
[TBL] [Abstract][Full Text] [Related]
40. Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells.
Harazono Y; Kho DH; Balan V; Nakajima K; Zhang T; Hogan V; Raz A
Oncotarget; 2014 Oct; 5(20):9992-10001. PubMed ID: 25393982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
